Drake RD - Search Results

1

A phase II evaluation of pemetrexed (Alimta, LY231514, IND #40061) in the treatment of recurrent or persistent endometrial carcinoma: a phase II study of the Gynecologic Oncology.

Miller DS, Blessing JA, Drake RD, Higgins R, McMeekin DS, Puneky LV, Krasner CN. Miller DS, et al. Among authors: drake rd. Gynecol Oncol. 2009 Dec;115(3):443-6. doi: 10.1016/j.ygyno.2009.09.004. Epub 2009 Oct 4. Gynecol Oncol. 2009. PMID: 19804902 Clinical Trial.

2

Oral dexamethasone attenuates Doxil-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies.

Drake RD, Lin WM, King M, Farrar D, Miller DS, Coleman RL. Drake RD, et al. Gynecol Oncol. 2004 Aug;94(2):320-4. doi: 10.1016/j.ygyno.2004.05.027. Gynecol Oncol. 2004. PMID: 15297168 Clinical Trial.

3

A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

Dizon DS, Blessing JA, Penson RT, Drake RD, Walker JL, Johnston CM, Disilvestro PA, Fader AN. Dizon DS, et al. Among authors: drake rd. Gynecol Oncol. 2012 May;125(2):367-71. doi: 10.1016/j.ygyno.2012.02.019. Epub 2012 Feb 21. Gynecol Oncol. 2012. PMID: 22366594 Free PMC article. Clinical Trial.

4

Gestational trophoblastic disease among Hispanic women: a 21-year hospital-based study.

Drake RD, Rao GG, McIntire DD, Miller DS, Schorge JO. Drake RD, et al. Gynecol Oncol. 2006 Oct;103(1):81-6. doi: 10.1016/j.ygyno.2006.01.042. Epub 2006 Mar 6. Gynecol Oncol. 2006. PMID: 16516953

5

A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA).

Simpkins F, Drake R, Escobar PF, Nutter B, Rasool N, Rose PG. Simpkins F, et al. Gynecol Oncol. 2015 Feb;136(2):240-5. doi: 10.1016/j.ygyno.2014.12.004. Epub 2014 Dec 6. Gynecol Oncol. 2015. PMID: 25485782 Clinical Trial.

6

Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.

Rao GG, Rogers P, Drake RD, Nguyen P, Coleman RL. Rao GG, et al. Among authors: drake rd. Gynecol Oncol. 2005 Jan;96(1):168-72. doi: 10.1016/j.ygyno.2004.09.009. Gynecol Oncol. 2005. PMID: 15589596 Clinical Trial.

7

Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.

Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC. Schorge JO, et al. Among authors: drake rd. Clin Cancer Res. 2004 May 15;10(10):3474-8. doi: 10.1158/1078-0432.CCR-03-0365. Clin Cancer Res. 2004. PMID: 15161704

8

Simplifying the preevacuation testing strategy for patients with molar pregnancy.

Knowles LM, Drake RD, Ashfaq R, Castrillon DH, Miller DS, Schorge JO. Knowles LM, et al. Among authors: drake rd. J Reprod Med. 2007 Aug;52(8):685-8. J Reprod Med. 2007. PMID: 17879828

9

Stage II uterine papillary serous carcinoma: Carboplatin/paclitaxel chemotherapy improves recurrence and survival outcomes.

Fader AN, Nagel C, Axtell AE, Zanotti KM, Kelley JL, Moore KN, Secord AA, Walsh CS, Huh WK, Gehrig PA, Gibbons H, Rose PG, Havrilesky LJ, Tuller E, Drake RD, Bottsford-Miller J, O'Malley DM; UPSC Consortium. Fader AN, et al. Among authors: drake rd. Gynecol Oncol. 2009 Mar;112(3):558-62. doi: 10.1016/j.ygyno.2008.11.016. Epub 2009 Jan 1. Gynecol Oncol. 2009. PMID: 19118888

10

Ovarian preservation in stage I low-grade endometrial stromal sarcomas.

Li AJ, Giuntoli RL 2nd, Drake R, Byun SY, Rojas F, Barbuto D, Klipfel N, Edmonds P, Miller DS, Karlan BY. Li AJ, et al. Obstet Gynecol. 2005 Dec;106(6):1304-8. doi: 10.1097/01.AOG.0000185511.91694.1e. Obstet Gynecol. 2005. PMID: 16319256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page